Morepen Laboratories (NSE:MOREPENLAB) Common Stock: ₹1,096 Mil (As of Mar. 2026)


NSE:MOREPENLAB Morepen Laboratories Ltd NSE:MOREPENLAB
74 GF Score
Price ₹54.66
GF Value ₹50.02
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Morepen Laboratories Common Stock?

Morepen Laboratories NSE:MOREPENLAB +2.82% 74 Common Stock is ₹1,096 Mil as of Mar. 2026. GuruFocus rates NSE:MOREPENLAB with a GF Score™ of 74/100 and a GF Value™ of ₹50.02 (Fairly Valued). The stock has 6 warning signs investors should review.

Morepen Laboratories's quarterly common stock declined from Sep. 2025 (₹1,096 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,096 Mil).

Morepen Laboratories's annual common stock increased from Mar. 2024 (₹1,022 Mil) to Mar. 2025 (₹1,096 Mil) but then stayed the same from Mar. 2025 (₹1,096 Mil) to Mar. 2026 (₹1,096 Mil).

Morepen Laboratories Common Stock Historical Data

* Premium members only.

The historical data trend for Morepen Laboratories's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Morepen Laboratories Common Stock Chart

Morepen Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 955.59 1,022.27 1,022.27 1,095.84 1,095.84

Morepen Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,095.84 0.00 1,095.84 0.00 1,095.84
NSE:MOREPENLAB
74GF Score
Morepen Laboratories Ltd NSE:MOREPENLAB
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Morepen Laboratories Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹1,096 Mil mean?
Morepen Laboratories (NSE:MOREPENLAB) has a Common Stock of ₹1,096 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Morepen Laboratories and its competitors.
Is Morepen Laboratories' Common Stock too high?
Morepen Laboratories' current Common Stock is ₹1,096 Mil. Overall, Morepen Laboratories has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Morepen Laboratories' Common Stock compare to ZTS and UTHR?
Morepen Laboratories' Common Stock of ₹1,096 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Morepen Laboratories and its competitors. Morepen Laboratories's current Common Stock is ₹1,096 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morepen Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Morepen Laboratories (NSE:MOREPENLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹50.02, compared to a current price of ₹54.66 — trading 9.3% above its estimated fair value. The current Common Stock is ₹1,096 Mil. Morepen Laboratories' overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Morepen Laboratories (NSE:MOREPENLAB), the current Common Stock is ₹1,096 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Morepen Laboratories (NSE:MOREPENLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Morepen Laboratories stock appears to be overvalued. The current stock price of ₹54.66 is trading 9.3% above its estimated GF Value™ of ₹50.02. GuruFocus considers Morepen Laboratories to be Fairly Valued.

Key valuation signals for NSE:MOREPENLAB:

  • Common Stock: ₹1,096 Mil
  • GF Value™: ₹50.02 vs. price of ₹54.66 (9.3% above fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the NSE:MOREPENLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Morepen Laboratories Business Description

Other Exchanges 500288:India
Address Udyog Vihar-III, Sector-20, 2nd Floor, Tower C, DLF Cyber Park, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
74GF Score

Get the complete analysis for NSE:MOREPENLAB

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹54.66
Price
₹50.02
GF Value